The effect of antiemetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in Stage I seminoma of the testis: A randomized pilot study

Clinical Oncology

Volumn 9, Issue 4, 1997, Pages 252-257

  Khoo, V S ^a   Rainford, K ^a   Horwich, A ^a   Dearnaley, D P ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Gastrointenstinal morbidity; Radiotherapy; Seminoma

Indexed keywords

ANTIEMETIC AGENT; METOCLOPRAMIDE; ONDANSETRON;

ABDOMINAL DISCOMFORT; ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; LETHARGY; MALE; MORBIDITY; NAUSEA; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADIATION FIELD; RANDOMIZED CONTROLLED TRIAL; SEMINOMA; VOMITING;

EID: 0030823220     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80011-8     Document Type: Article

References (19)

1. Thomas G. Controversies in the management of testicular seminoma. Cancer 1985;55:2296-302.
2. Willan BD, McGowan DG. Seminoma of the testis: a 22-year experience with radiation therapy. Int J Radiat Oncol Biol Phys 1985;11:1769-75.
3. Duncan W, Munro AJ. The management of testicular seminoma: Edinburgh 1970-1981. Br J Cancer 1987;55:443-8.
4. Fossa SD, Aass N, Kaalhus O. Radiotherapy for testicular seminoma Stage I: treatment results and long-term postirradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 1989;16:383-8.
5. Peckham MJ, Hamilton CR, Horwich A, et al. Surveillance after orchidectomy for Stage I seminoma of the testis. Br J Urol 1987;59:343-7.
6. Horwich A, Alsanjari N, A'Hern R, et al. Surveillance following orchidectomy for Stage I testicular seminoma. Br J Cancer 1992;65:775-8.
7. Warde PR, Gospodarowicz MK, Goodman PJ, et al. Results of a policy of surveillance in Stage I testicular seminoma. Int J Radiat Oncol Biol Phys 1993;27:11-15.
8. Hamilton C, Horwich A, Easton A, et al. Radiotherapy for Stage I seminoma testis: results of treatment and complications. Radiother Oncol 1986;6:115-20.
9. Fossa SD, Aass N, Kaalhus O. Long-term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer. Cancer 1989;64:404-8.
10. Blackwell CP, Harding SM. Clinical pharmacology of ondansetron. Eur J Cancer Clin Oncol 1989;25:521-2.
11. Fayers P. MRC Quality of life studies using a daily diary card - practical lessons learned from cancer trials. Quality Life Res 1995;4:343-52.
12. Moul JW, Robertson JE, George SL, et al. Complications of therapy for testicular cancer. J Urol 1989;142:1491-6.
13. Dosoretz DE, Shipley WU, Blitzer PH, et al. Megavoltage irradiation for pure testicular seminoma: results and patterns of failure. Cancer 1981;48:2184-90.
14. Schultz HP, von der Maase A, Rorth M, et al. Testicular seminoma in Denmark 1976-1980. Results of treatment. Acta Radiol 1984;23:263-70.
15. Yeoh E, Razali M, O'Brien PC. Radiation therapy for early stage seminoma of the testis. Analysis of survival and gastrointestinal toxicity in patients treated with modern megavoltage techniques over 10 years. Australas Radiol 1993;37:367-9.
16. Aass N, Fosså SD, Host H. Acute and subacute side effects due to infradiaphragmatic radiotherapy for testicular cancer: a prospective study. Int J Radiat Oncol Biol Phys 1992;22:1057-64.
17. Priestman TJ, Roberts JT, Upadhyaya BK. Randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. Clin Oncol 1993; 5:358-63.
18. Collis CH, Priestman TJ, Priestman S, et al. The final assessment of a randomized double-blind comparative study on ondansetron vs metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation [letter]. Clin Oncol 1991;3:241-2.
19. Fosså SD, Horwich A, Russell JM, et al. Optimal field size in adjuvant radiotherapy (XRT) of Stage I seminoma - a randomised trial [abstract 595]. Proc ASCO 1996;15:239.